Proteon Therapeutics Inc. Secures $38,000,000 Series B Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=59912525-3ffa-4b5e-a87d-a1498c36cbe1&Preview=1 -
Date
3/5/2009 -
Company Name
Proteon Therapeutics Inc. -
Mailing Address
200 West Street Waltham, MA 02451 -
Company Description
Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring. -
Website
http://www.proteontherapeutics.com -
Transaction Type
Venture Equity -
Transaction Amount
$38,000,000 -
Transaction Round
Series B -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
MPM Capital -
Venture Investor
Undisclosed -
Venture Investor
TVM Capital -
Venture Investor
Skyline Ventures -
Venture Investor
Prism VentureWorks -
Venture Investor
Intersouth Partners
